EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial

Vivek Y Reddy iD, Jacob S Koruth iD, Petr Peichl iD, Jan Petru, Moritoshi Funasako iD, Jan Skoda, Keita Watanabe iD, Moritz Nies, Josef Kautzner iD, Petr Neuzil iD

Circulation · 16.12.2025 · 152 (24) · 1691-1704

DOI: 10.1161/circulationaha.125.077025 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Circulation, erschienen am 16.12.2025. Verfasst von Vivek Y Reddy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, New York, NY (V.Y.R., J.S.K., K.W., M.N.). Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Catheter Ablation, Cicatrix. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Field Medical Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Unlike the tremendous progress made in atrial fibrillation ablation, the greatest unmet clinical need is for innovative ablation treatments for scar-related ventricular tachycardia (VT), particularly given the thick, often fibrotic tissue characteristic of the scarred substrate. A focal pulsed field ablation (PFA) catheter with a novel waveform was designed: high voltage to provide tissue penetration and low energy (using short-duration pulses) to avoid tissue overheating. We present the outcomes of VCAS (Ventricular Catheter Ablation Study), a first-in-human study of this PFA catheter to ablate scar-related VT. METHODS: An investigational 8.5F force-sensing PFA catheter was used for scar-VT ablation in ischemic or nonischemic substrates. Pulsed field lesions consisted of 5 applications, each 10 kV) monophasic waveform with QRS synchronization. The PFA catheter was localized by electrical impedance-based navigation. A subcohort of patients without previous cardiac surgery underwent epicardial ventricular mapping at baseline and after endocardial PFA to assess for transmurality of endocardial pulsed field lesions. Study end points included procedural efficiency, safety, and effectiveness to final follow-up of 6 months. RESULTS: At 2 centers, 26 patients underwent ablation: 66±9 years of age, 4% women, left ventricular ejection fraction 32±10%, VT storm 42%, previous VT ablation 42%. Acute procedural success, achieved in 24 (92%) patients, required 21 (interquartile range, 14–24) lesions per patient with a transpired ablation time of 31 minutes (19–42). Clinical VT was induced in 14 of 16 patients (88%) before ablation and 1 of 16 patients (6%, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularCatheter AblationCicatrixHumansFemaleMaleMiddle AgedAgedTreatment Outcome

Stichwörter der Autor:innen

high-voltagepostmyocardial infarctionpulsed field ablationscar-relatedtransmuralventricular tachycardia

Autor:innen und Institutionen

  • Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, New York, NY (V.Y.R., J.S.K., K.W., M.N.).
  • Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (P.P., J.K.).
  • Cardiology Department, Homolka Hospital, Prague, Czech Republic (J.P., M.F., J.S., P.N.).

ORCID-Profile: Vivek Y Reddy, Jacob S Koruth, Petr Peichl, Moritoshi Funasako, Keita Watanabe, Josef Kautzner, Petr Neuzil

Förderung

  • Field Medical Inc.

Zitieren

APA

Reddy, V. Y., Koruth, J. S., Peichl, P., Petru, J., Funasako, M., Skoda, J., Watanabe, K., Nies, M., Kautzner, J., & Neuzil, P. (2025). High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial. Circulation, 152(24), 1691-1704. https://doi.org/10.1161/circulationaha.125.077025

Vancouver

Reddy VY, Koruth JS, Peichl P, Petru J, Funasako M, Skoda J, et al. High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial. Circulation. 2025;152(24):1691-1704. doi:10.1161/circulationaha.125.077025

BibTeX
@article{Reddy2025,
  author = {Reddy, Vivek Y and Koruth, Jacob S and Peichl, Petr and Petru, Jan and Funasako, Moritoshi and Skoda, Jan and Watanabe, Keita and Nies, Moritz and Kautzner, Josef and Neuzil, Petr},
  title = {High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial},
  journal = {Circulation},
  year = {2025},
  volume = {152},
  number = {24},
  pages = {1691--1704},
  doi = {10.1161/circulationaha.125.077025}
}
Kostenlos starten →